Lyra Therapeutics, Inc(NASDAQ:LYRA) 
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's XTreo technology platform is designed to deliver...
Website: http://www.lyratherapeutics.com
Founded: 2005
Full Time Employees: 33
CEO: Maria Palasis
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 5.50
H 6.00
L 5.00
C 6.00
V 4,252,263
10EMA 6.00
20EMA 6.00
60EMA 6.00
120EMA 6.00
250EMA 6.00